A previously healthy 47-year-old woman presents with an ascending, nonpruritic rash of 3 days' duration on her legs. She reports that the rash began on her ankles following a day of gardening. She does not recall any recent insect bites and denies chest pain, dyspnea, abdominal pain, fever, arthralgia, arthritis, cough, and hemoptysis. She has never had a similar rash before. The patient's only medication is an oral antihistamine for seasonal allergies. She has no known drug allergies.
The diffuse, uniformly distributed maculopapular rash involves the lower extremities bilaterally from the ankles to the knees. The lesions are red and nonblanching, with a central darkened area, and range from 1 to 5 mm in diameter. No lymphadenopathy is noted. Results of chest, cardiac, and abdominal examinations are unremarkable. Laboratory studies reveal an elevated erythrocyte sedimentation rate (34 mm/h) and C-reactive protein level (2.0 mg/dL). Complete blood cell count with differential, comprehensive metabolic panel, prothrombin time, partial thromboplastin time, and international normalized ratio are all within normal limits.
1. Jordan KM, Edwards CJ, Arden NK. Allergic vasculitis associated with celecoxib. Rheumatology (Oxford). 2002;41:1453-1455.
2. Lacour JP, Castanet J, Perrin C, et al. Cutaneous leukocytoclastic vasculitis and renal cancer: two cases. Am J Med. 1993;94:104-108.
3. Stone JH. Hypersensitivity vasculitis. In: Imboden J, Hellmann D, Stone J, eds. Current Diagnosis & Treatment in Rheumatology. 2nd ed. New York: McGraw-Hill; 2007:308-311.
4. Requena L, Sánchez Yus E, Kutzner H. Panniculitis. In: Wolff K, Goldsmith LA, Katz SI, et al, eds. Fitzpatrick's Dermatology in General Medicine. 7th ed. 2 vols. New York: McGraw-Hill; 2008.
5. McCalmont TH. Diseases of the skin. In: McPhee SJ, Ganong WF, eds. Pathophysiology of Disease: An Introduction to Clinical Medicine. 5th ed. New York: McGraw-Hill; 2006.
6. Callen JP. Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol. 1985;13(2, pt 1):193-200.
7. Sais G, Vidaller A, Jucglà A, et al. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial. Arch Dermatol. 1995;131:1399-1402.
8. Keogh KA, Ytterberg SR, Fervenza FC, et al. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open label pilot trial. Am J Respir Crit Care Med. 2006;173:180-187.